Uzsoki Utcai Korhaz

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Multiple sclerosis1 trial
• Osteoarthritis1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Actelion1 trial
• Daiichi Sankyo1 trial
• G1 Therapeutics, Inc.1 trial
• Smith & Nephew, Inc.1 trial
• Stemline Therapeutics, Inc.1 trial

Running trials

• Active, not recruiting

  Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

  NCT04656652· Phase 3· Daiichi Sankyo· Source

Closed trials

• Terminated

  Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab

  NCT04887831· Phase 2· G1 Therapeutics, Inc.· Source

• Completed

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· Phase 3· Stemline Therapeutics, Inc.· Source

• Completed

  Agili-C™ Implant Performance Evaluation

  NCT03299959· Smith & Nephew, Inc.· Source

• Completed

  Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis

  NCT03232073· Phase 3· Actelion· Source